top of page
laptop red.png

LAPTOP (NEAT44) – The Late Presenter Treatment Optimisation Study  

An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients with Advanced HIV-Disease 


SPONSOR: NEAT ID Foundation 


Sponsor code: NEAT44 

EudraCT: 2018-003481-13 


Phase:  III


Indication:  ART-naïve HIV-1 infected patients


Countries: UK, France, Germany, Spain, Ireland, Ukraine, Romania & Poland

Sites: 55


Status:  Ongoing, closed to recruitment 

bottom of page